Power Law company profile

Orna Therapeutics

Biotech & Life Sciences · Cambridge, United States · Founded 2019 Unicorn

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Orna Therapeutics - Ahead of the Curve

Investors

11 investors on Orna Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 9 investors entered at this stage

Taiho Ventures

Kite Pharma

PAG

Bristol-Myers Squibb

F2 Ventures

Astellas Venture

Taiho Pharma

MPM BioImpact

Novartis Institutes

Series B+ 2 investors entered at this stage

BioImpact Capital

Merck & Co.

Global footprint

Where Orna Therapeutics has talent and traffic

AI talent share

0.6% of workforce is AI talent
(1 of 172 staff)

Core AI10.58%

Other AI00%

Non-AI workforce17199.42%

Workforce by country

3 countries with
team presence

🇺🇸 United States98.4%

🇪🇸 Spain0.8%

🇪🇹 Ethiopia0.8%

3 countries shown

Web traffic by country

11K monthly visits
across markets

🇺🇸 United States64.5%

🇬🇧 United Kingdom14.5%

🇮🇳 India11.8%

🇮🇹 Italy4.5%

🇭🇰 Hong Kong0.9%

Top 5 markets shown

Patent intelligence

$5M patent portfolio · 15 active families

Estimated portfolio value

$5M

0.31% of valuation · 43.1× the top peer Capstan Therapeutics ($108k)

15 active patent families

Where Orna Therapeutics innovates NanoparticlePolynucleotideCircular RNANucleotideMolecular biology

Where Orna Therapeutics concentrates vs peers

Each axis is a top-10 topic across Orna Therapeutics and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Sentiment on X

What X is saying about Orna Therapeutics

An AI-synthesized read of the highest-engagement posts about Orna Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Orna Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles